sur RedChip Companies, Inc. (Media Suite) (NASDAQ:JUNS)
Greenwich LifeSciences Interview to Feature on Bloomberg TV's RedChip Show
RedChip Companies has announced that an interview with Greenwich LifeSciences, Inc. will be broadcast on the RedChip Small Stocks, Big Money™ show on Bloomberg TV. Scheduled for June 28 at 7 p.m. ET, the program will reach an estimated 73 million U.S. households.
Snehal Patel, CEO of Greenwich LifeSciences, will discuss the company's GLSI-100 breast cancer vaccine, highlighting its success in prior trials and the ongoing Phase III FLAMINGO-01 trial across 120 sites in the U.S. and Europe. Patel aims for accelerated commercialization with advanced manufacturing readiness and academic collaborations.
Greenwich LifeSciences is focused on developing GP2, a HER2-derived peptide immunotherapy aimed at preventing breast cancer recurrence. GLSI is a client of RedChip Companies.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de RedChip Companies, Inc. (Media Suite)